Effect of treatment regimens in severe COVID pneumonia at an Indian tertiary care hospital: An observational, real-world study.

Chopra, Manu; Joshi, Aditya; Dey, Saikat; Kapoor, Rajan; Nair, Ranjith K; Bhalla, Sharad; Nilakantan, Ajith

Chopra, Manu; Joshi, Aditya; Dey, Saikat; Kapoor, Rajan; Nair, Ranjith K; Bhalla, Sharad; Nilakantan, Ajith.

Afiliação

Chopra M; Pulmonologist, Command Hospital (Eastern Command), Kolkata, India.
Joshi A; Intensivist (Anaesthesia), Command Hospital (Eastern Command), Kolkata, India.
Dey S; Medical Officer, Command Hospital (Eastern Command), Kolkata, India.
Kapoor R; Head of Department (Medicine), Command Hospital (Eastern Command), Kolkata, India.
Nair RK; Commandant, Military Hospital Jaipur, India.
Bhalla S; Microbiologist, Command Hospital (Eastern Command), Kolkata, India.
Nilakantan A; Commandant, Command Hospital (Eastern Command), Kolkata, India.

Med J Armed Forces India ; 78(4): 469-474, 2022 Oct.

Article em En | MEDLINE | ID: mdl-35919732

Palavras-chave

Pulse steroids; Remdesivir; Severe COVID; Tocilizumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google